The study found that the worth of this market was $72.80 billion in 2021 and is anticipated to grow at a CAGR of 4.30% in between 2022 and 2030
FREMONT, Calif., March 13, 2023/ PRNewswire/– BIS Research, the global leader in offering market intelligence on deep technologies, has actually released its most current research study entitled U.S. Women Health Laboratory Testing Market – A Global and Regional Analysis..
According to this study, the U.S. ladies health lab screening market was valued at $72.80 billion in 2021 and is forecasted to reach $106.8 billion by 2030.
According to the report, the list below elements are accountable for the increase in need for females health lab screening in the U.S.:.
Regardless of this, the U.S. females health laboratory screening market still deals with some restraints that impede its growth and require to be attended to in order to improve the market.
Factors such as strict regulatory guidelines related to laboratory testing impede the marketplace growth in the U.S., and the variation in awareness of pregnancy and fertility concerns in the different areas of the U.S. are even more anticipated to impact the U.S. women health lab testing market adversely.
Obstetrician and Gynecology (OB/GYN) Segment to Account for a Major Share in the U.S. Women Health Laboratory Testing Market.
In the study, the U.S. women health lab testing market has actually been segmented into genetic cancer, carrier screening, prenatal screening and diagnostic screening, reproductive health and infectious illness, and OB/GYN. Each sector consists of various laboratory tests or services worrying the particular section.
According to the report released by BIS Research, the OB/GYN section held the biggest share in the U.S. women health lab testing market, accounting for $29.0 billion in 2021, followed by the reproductive health and infectious diseases sector at $24.2 billion in 2021.
Wish to discover more about this emerging pattern? Ask for a free sample of the report here à.
Analysts Take on the marketplace Projection.
There has been a constant boost in various diseases in females in the U.S. which leads to serious consequences. The substantial boost in the prevalence of particular contagious illness such as human papillomavirus (HPV), human immunodeficiency infection (HIV), HSV, liver disease, chlamydia, gonorrhea, syphilis, and other sexually transmitted diseases and cancer in women in the U.S. over the past couple of years has led to an increased need for lab testing, hence driving the growth of the U.S. women health lab testing market.”.
Talk to an expert analyst for more details..
About BIS Research:.
BIS Research is an international B2B market intelligence and advisory firm focusing on deep technology and associated emerging trends which can interfere with the marketplace dynamics in the future. We publish more than 200 market intelligence studies every year that concentrate on a number of deep technology verticals..
Our strategic market analysis stresses on market evaluations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market information, and other crucial market parameters useful in the strategic decision-making for senior management..
BIS Research provides distribute along with custom research studies and skilled consultations to firms, supplying them with particular and actionable insights on unique technology markets, organization designs, and competitive landscapes..
Contact: Head of MarketingEmail: [e-mail secured] BIS Research Inc. 39111 PASEO PADRE PKWY STE 313, FREMONT, CA, 94538-1686Visit our Blog @ https://bisresearch.com/news Get Expert Insights @ https://community.insightmonk.comConnect with us on LinkedIn @ https://www.linkedin.com/company/bis-researchConnect with us on [e-mail protected] https://twitter.com/BISResearch. This material was initially released here.

According to Swati Sood, Principal Analyst, BIS Research, “Womens health differs from that of guys in numerous distinct ways. There has actually been a constant increase in various illness in females in the U.S. which leads to serious consequences. The timely diagnosis/testing of a disease is essential for getting fair management and treatment for the disease. The considerable boost in the prevalence of particular infectious diseases such as human papillomavirus (HPV), human immunodeficiency virus (HIV), HSV, liver disease, chlamydia, gonorrhea, syphilis, and other sexually transmitted diseases and cancer in ladies in the U.S. over the previous couple of years has led to an increased demand for laboratory screening, hence driving the growth of the U.S. females health lab testing market.”.